2012 in Review: 10 Stories That Affected HIV/AIDS in Black America

Our latest: The first in a two-part series for the Black AIDS Institute: "2012 Year in Review: 10 Stories That Affected HIV/AIDS in Black America."

Truvada is among those making major news this year. Gilead Sciences' antiretroviral "cocktail" became the first medication ever to be approved for HIV prevention last July. It is also part of an aggressive treatment strategy for the newly infected known as "treatment as prevention."